scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in scPharmaceuticals Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −8 vs. Q1 2021
- Shares held
- 16.0M
- −1.12M (−6.6%) vs. Q1 2021
- Total value
- $97.9M
- −$16.1M (−14.1%) vs. Q1 2021
- New holders
- 5
- 4 more added
- Sold out
- 13
- 23 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,797,148 | $29.3M | 0.30% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 3,831,474 | $23.4M | 5.89% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,731,170 | $16.7M | 0.27% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 1,095,024 | $6.69M | 1.20% | −213,675−16.3% | Reduced |
| J. Goldman & Co LP | 720,877 | $4.41M | 0.28% | +522,451+263.3% | Added |
| AIGH Capital Management LLC | 642,154 | $3.92M | 1.06% | −212,988−24.9% | Reduced |
| Vanguard Group Inc | 608,948 | $3.72M | 0.00% | −34,507−5.4% | Reduced |
| Renaissance Technologies LLC | 216,486 | $1.32M | 0.00% | +25,100+13.1% | Added |
| Russell Investments Group, Ltd. | 194,238 | $1.19M | 0.00% | +194,238 | New |
| Worth Venture Partners, LLC | 163,994 | $1.00M | 0.37% | −50,066−23.4% | Reduced |
| Jacobs Levy Equity Management, Inc | 138,604 | $847.0K | 0.01% | −2,363−1.7% | Reduced |
| Boothbay Fund Management, LLC | 124,827 | $763.0K | 0.03% | −9,689−7.2% | Reduced |
| Goldman Sachs Group Inc | 115,264 | $704.0K | 0.00% | −533,506−82.2% | Reduced |
| Bridgeway Capital Management, LLC | 102,200 | $624.0K | 0.01% | −500−0.5% | Reduced |
| Geode Capital Management, LLC | 66,475 | $406.0K | 0.00% | −31,605−32.2% | Reduced |
| BlackRock Inc. | 62,197 | $380.0K | 0.00% | −266,972−81.1% | Reduced |
| Morgan Stanley | 61,164 | $374.0K | 0.00% | +6,875+12.7% | Added |
| Millennium Management LLC | 57,717 | $353.0K | 0.00% | +57,717 | New |
| Northern Trust Corp | 49,885 | $305.0K | 0.00% | −64,988−56.6% | Reduced |
| Dimensional Fund Advisors LP | 44,827 | $273.0K | 0.00% | −2,051−4.4% | Reduced |
| DAFNA Capital Management LLC | 38,891 | $238.0K | 0.05% | 00.0% | Unchanged |
| Zacks Investment Management | 36,989 | $226.0K | 0.00% | +36,989 | New |
| Bank of New York Mellon Corp | 34,643 | $211.0K | 0.00% | −12,034−25.8% | Reduced |
| Ergoteles LLC | 27,872 | $170.0K | 0.00% | +27,872 | New |
| First Trust Advisors LP | 23,614 | $144.0K | 0.00% | −823−3.4% | Reduced |
| HRT Financial LP | 20,261 | $123.0K | 0.00% | +20,261 | New |
| Two Sigma Advisers, LP | 11,000 | $67.0K | 0.00% | −700−6.0% | Reduced |
| JPMorgan Chase & Co | 3,174 | $19.0K | 0.00% | −15,856−83.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,112 | $13.0K | 0.00% | −621−22.7% | Reduced |
| Bank of America Corp | 1,493 | $9.00K | 0.00% | −6,771−81.9% | Reduced |
| Barclays PLC | 770 | $5.00K | 0.00% | −5,079−86.8% | Reduced |
| Royal Bank of Canada | 874 | $5.00K | 0.00% | +33+3.9% | Added |
| UBS Group AG | 704 | $4.00K | 0.00% | −1,680−70.5% | Reduced |
| Advisor Group Holdings, Inc. | 357 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 259 | $1.58K | 0.00% | −568−68.7% | Reduced |
| New York State Common Retirement Fund | 50 | $0 | 0.00% | −6,850−99.3% | Reduced |
| Wells Fargo & Company | 60 | $0 | 0.00% | −2,136−97.3% | Reduced |
| Captrust Financial Advisors | 39 | $0 | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −355,690−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −104,119−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −32,739−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −14,397−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,726−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −10,596−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,495−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −4,079−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −827−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −465−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −470−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −475−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −261−100.0% | Sold out |